Patients with atrial fibrillation or flutter were more likely to be White, male, older, and have wild-type ATTR-CM.
Recurrence risk rose sharply with higher scores, with marked differences in 1- and 2-year outcomes. The preoperative circulating tumor cell-aspartate aminotransferase-to-lymphocyte ratio index ...
Rare Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...
Test Your Knowledge About Eteplirsen for the Treatment of DMD Test Your Knowledge About the Treatment of DMD Test Your Knowledge About the Epidemiology of DMD Test Your Knowledge About the ...
Findings support routine pain assessment and targeted pain management in long-term care of acromegaly. Pain appears to be a dominant determinant of physical quality of life (QoL) in patients with ...
Three months after the start of treatment, 65.3% of patients given 100 mg of rituximab weekly for 4 weeks and 64.7% of those given a single dose of 375 mg/m2 achieved overall response. Low-dose ...
The CAPTIVATE trial met its target of at least 20 responders among the first 40 participants before all 40 completed part A. Dianthus Therapeutics announced an early “go” decision for claseprubart for ...
Preclinical findings show DYNE-401 enables lower and less frequent dosing while targeting both skeletal muscle and the CNS in Pompe disease. Even when administered every other month, DYNE-401 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results